Counter-regulatory ‘Renin-Angiotensin’ System-based Candidate Drugs to Treat COVID-19 Diseases in SARS-CoV-2-infected Patients - Aix-Marseille Université Access content directly
Journal Articles Infectious Disorders - Drug Targets Year : 2020

Counter-regulatory ‘Renin-Angiotensin’ System-based Candidate Drugs to Treat COVID-19 Diseases in SARS-CoV-2-infected Patients

Cédric Annweiler
Zhijian Cao
  • Function : Author
Yingliang Wu
  • Function : Author
Emmanuelle Faucon
  • Function : Author
Stéphanie Mouhat
  • Function : Author
Hervé O Kovacic
Jean-Marc Sabatier
No file

Dates and versions

hal-03357854 , version 1 (29-09-2021)

Identifiers

Cite

Cédric Annweiler, Zhijian Cao, Yingliang Wu, Emmanuelle Faucon, Stéphanie Mouhat, et al.. Counter-regulatory ‘Renin-Angiotensin’ System-based Candidate Drugs to Treat COVID-19 Diseases in SARS-CoV-2-infected Patients. Infectious Disorders - Drug Targets, 2020, 20 (4), pp.407-408. ⟨10.2174/1871526520666200518073329⟩. ⟨hal-03357854⟩
17 View
0 Download

Altmetric

Share

Gmail Facebook X LinkedIn More